Cargando…

Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps

Approximately one third of epilepsy patients do not become seizure free with antiseizure medications. This treatment gap motivates research for new therapeutic options, such as cannabidiol (CBD). CBD differs from other cannabis derivatives because of its consistent efficacy and lack of a psychoactiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Guilherme Diogo, Del Guerra, Felipe Borelli, de Oliveira Lelis, Maira, Pinto, Lécio Figueira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604476/ https://www.ncbi.nlm.nih.gov/pubmed/33192966 http://dx.doi.org/10.3389/fneur.2020.531939

Ejemplares similares

Cannabidiol for Treatment of Childhood Epilepsy–A Cross-Sectional Survey
por: Klotz, Kerstin A., et al.
Publicado: (2018)

Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy
por: Klotz, Kerstin A., et al.
Publicado: (2019)

COVID-19 and epilepsy: How are people with epilepsy in Brazil?
por: Guilhoto, Laura Maria, et al.
Publicado: (2021)

Knowledge and Attitude of Saudi Physicians Toward Cannabidiol for Pediatric Epilepsy: A Cross-Sectional Study
por: Alsolamy, Renad M, et al.
Publicado: (2023)

Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)

Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study
por: D'Onofrio, Gianluca, et al.
Publicado: (2020)

The effect of cannabidiol on seizure features and quality of life in drug-resistant frontal lobe epilepsy patients: a triple-blind controlled trial
por: Ebadi, Seyyed Reza, et al.
Publicado: (2023)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

Cannabidiol in Treatment of Autism Spectrum Disorder: A Case Study
por: Ma, Lucy, et al.
Publicado: (2022)

Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries
por: Aychman, Mackenzie M., et al.
Publicado: (2023)

Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents
por: Dias Viegas, Flávia P., et al.
Publicado: (2022)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Metabolic Evaluation of Epilepsy: A Diagnostic Algorithm With Focus on Treatable Conditions
por: van Karnebeek, Clara D. M., et al.
Publicado: (2018)

Status epilepticus: review on diagnosis, monitoring and treatment
por: Pinto, Lecio Figueira, et al.
Publicado: (2022)

Cannabidiol in epilepsy: The indications and beyond
por: Ryan, Melody
Publicado: (2020)

Cannabidiol and Tetrahydrocannabinol Use in Parkinson’s Disease: An Observational Pilot Study
por: Sousa, Amber, et al.
Publicado: (2023)

Don’t Fear the Reefer—Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy
por: Perry, M. Scott
Publicado: (2019)

Decision-making strategies for reperfusion therapies: navigating through stroke trials gaps
por: Pellegrino, Mateus Paquesse, et al.
Publicado: (2022)

Role of DNA Methylation and Adenosine in Ketogenic Diet for Pharmacoresistant Epilepsy: Focus on Epileptogenesis and Associated Comorbidities
por: Chen, Fan, et al.
Publicado: (2019)

Parent perceptions and decision making about treatments for epilepsy: a qualitative evidence synthesis
por: Uhl, Stacey, et al.
Publicado: (2023)

Editorial: Source Imaging in Drug Resistant Epilepsy - Current Evidence and Practice
por: Beniczky, Sándor, et al.
Publicado: (2020)

Neuropathic Pain in Multiple Sclerosis and Its Animal Models: Focus on Mechanisms, Knowledge Gaps and Future Directions
por: Mirabelli, Ersilia, et al.
Publicado: (2021)

Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study
por: Huntsman, Richard J., et al.
Publicado: (2019)

Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome
por: Iannone, Luigi Francesco, et al.
Publicado: (2021)

Local Functional Connectivity as a Pre-Surgical Tool for Seizure Focus Identification in Non-Lesion, Focal Epilepsy
por: Weaver, K. E., et al.
Publicado: (2013)

Evidence for the Role of Magnetic Source Imaging in the Presurgical Evaluation of Refractory Epilepsy Patients
por: Carrette, Evelien, et al.
Publicado: (2019)

Cannabidiol and epilepsy in Brazil: a current review
por: Oshiro, Carlos André, et al.
Publicado: (2022)

Biological rhythms and epilepsy treatment
por: Næsgaard, Jon Andreas Rugstad, et al.
Publicado: (2023)

Epileptic Phenotype and Cannabidiol Efficacy in a Williams–Beuren Syndrome Patient With Atypical Deletion: A Case Report
por: Nicotera, Antonio G., et al.
Publicado: (2021)

Hyperbaric Oxygen Therapy as a Complementary Treatment in Glioblastoma—A Scoping Review
por: Alpuim Costa, Diogo, et al.
Publicado: (2022)

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
por: Silvestro, Serena, et al.
Publicado: (2019)

Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy
por: Davis, Brittney H., et al.
Publicado: (2021)

The Gaps Between Current Management of Intracerebral Hemorrhage and Evidence-Based Practice Guidelines in Beijing, China
por: Li, Di, et al.
Publicado: (2018)

Cognitive Impairment After Intracerebral Hemorrhage: A Systematic Review of Current Evidence and Knowledge Gaps
por: Potter, Thomas, et al.
Publicado: (2021)

Circadian Rhythms and Epilepsy: A Suitable Case for Absence Epilepsy
por: Smyk, Magdalena K., et al.
Publicado: (2020)

Metabolic Control of Epilepsy: A Promising Therapeutic Target for Epilepsy
por: Fei, Yanqing, et al.
Publicado: (2020)

Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study
por: Liguori, Claudio, et al.
Publicado: (2023)

Occipital Lobe Epilepsy With Ictal Fear: Evidence From a Stereo-Electroencephalography (sEEG) Case
por: Wang, Jing, et al.
Publicado: (2018)

Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiology
por: Hickman, L. Brian, et al.
Publicado: (2023)

Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action
por: Mlost, Jakub, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_br4q748o523ob59p7avertkrfg